Cite

HARVARD Citation

    Sahai, V. et al. (2022). A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01. Cancer. 128 (19), pp. 3523-3530. [Online]. 
  
Back to record